-
Sector Analysis
Electrical Activity Testing Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Electrical Activity Testing Market Report Overview The electrical activity testing market was valued at $1.31 billion in 2023 and will grow at a CAGR of more than 1% from 2023 to 2033. Neurodiagnostic tests are used to diagnose suspected neurological disorders through EEG, MEG, or EMG by looking at brain activity. One of the key drivers of EEG and EMG markets is the increase in the aging population. This sector of the population is prone to developing neurological disorders, such...
-
Product Insights
Cutaneous Mycosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Cutaneous Mycosis - Drugs In Development, 2023’, provides an overview of the Cutaneous Mycosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cutaneous Mycosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Stomatitis (Sore Mouth) – Drugs In Development, 2023
Global Markets Direct’s, ‘Stomatitis (Sore Mouth) - Drugs In Development, 2023’, provides an overview of the Stomatitis (Sore Mouth) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Stomatitis (Sore Mouth), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Oral Mucositis – Drugs In Development, 2023
Global Markets Direct’s, ‘Oral Mucositis - Drugs In Development, 2023’, provides an overview of the Oral Mucositis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Oral Mucositis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Onychomycosis (Tinea Unguium) – Drugs In Development, 2023
Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Drugs In Development, 2023’, provides an overview of the Onychomycosis (Tinea Unguium) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Onychomycosis (Tinea Unguium), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Mycoses – Drugs In Development, 2023
Global Markets Direct’s, ‘Mycoses - Drugs In Development, 2023’, provides an overview of the Mycoses pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mycoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ibrutinib in Relapsed Chronic Lymphocytic Leukemia (CLL)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ibrutinib in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug Details: Ibrutinib (Imbruvica) is an anti-neoplastic agent....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Terbinafine Hydrochloride in Onychomycosis (Tinea Unguium)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Terbinafine Hydrochloride in Onychomycosis (Tinea Unguium) report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aminolevulinic Acid Hydrochloride in Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aminolevulinic Acid Hydrochloride in Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Aminolevulinic Acid Hydrochloride in Anemia Drug Details:Aminolevulinic acid hydrochloride (5-ALA) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bupivacaine Hydrochloride in Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bupivacaine Hydrochloride in Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Bupivacaine Hydrochloride in Oral MucositisDrug Details:Bupivacaine hydrochloride is under development for the...